Pirquitasite Ag2ZnSnS4 (AZTS) nanocrystals (NCs) are emergent, lead-free emissive materials in the coinage chalcogenide family with applications in optoelectronic technologies. Like many multinary nanomaterials, their phase-pure synthesis is complicated by the generation of e.g. binary/ternary chalcogenide and metallic impurities. Here, we develop a stepwise synthetic procedure that controls the size, morphology, and transformations of acanthite-like (Ag2S) and canfieldite-like (Ag8SnS6) intermediates. This reaction scheme grants the production of small AZTS NCs (diameter: 2.1–4.0 nm) that have not been achieved through established single-injection procedures—expanding the accessible range of quantum-confined AZTS emission to shorter wavelengths (λ: 650–740 nm). We show that the initial sulfur stoichiometry is the key handle for template-size tunability and reveal that temporally separating transformation steps is crucial to obtaining phase-pure AZTS NCs with emission λ<740 nm. We then use NMR and optical spectroscopies to demonstrate that the installation of thiol ligands improves colloidal stability, while exposure to carboxylic acids does not. Finally, facilitated by this enhanced synthetic control, we show that our ultra-small AZTS NCs can act as effective, less-toxic sensitizers for red-to-blue triplet fusion upconversion. Our results highlight transferrable insights for the synthesis and post-synthetic treatment of complex less-toxic quaternary nanocrystalline systems.
No takes yet. Share an insight, caveat, or question.
Villanueva et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: